GLP-1 is a natural hormone in the intestines that regulates blood sugar levels and appetite. It stimulates insulin secretion, inhibits glucagon release, and slows gastric emptying, improving blood ...
The drug targets both GLP-1 and another hormone, amylin. Novo Nordisk also agreed to spend up to $1.1 billion last year to acquire Inversago Pharma, gaining an experimental oral drug called ...
Right on the heels of oral semaglutide is a group of drugs led by Eli Lilly’s orforglipron, an oral medication that also targets GLP-1, which is a hormone implicated in insulin regulation ...